Literature DB >> 18611425

Protective effect of captopril and enalaprilat, angiotensin-converting enzyme inhibitors, on para-nonylphenol-induced *OH generation and dopamine efflux in rat striatum.

Toshio Obata1, Shigehiro Takahashi, Yoshitomo Kashiwagi, Shunichiro Kubota.   

Abstract

We recently reported that para-nonylphenol, an environmental chemical, induced hydroxyl radical (*OH) formation in rat striatum. In this study we examined the antioxidant effects of angiotensin-converting enzyme inhibitors (captopril or enalaprilat) on para-nonylphenol (nonylphenol) and 1-methyl-4-phenylpyridinium ion (MPP(+))-induced hydroxyl radical (*OH) formation and dopamine (DA) efflux in extracellular fluid of rat striatum, using a microdialysis technique. para-Nonylphenol clearly enhanced *OH formation and DA efflux induced by MPP(+). When captopril or enalaprilat was infused in nonylphenol and MPP(+)-treated rats, DA efflux and OH formation significantly decreased, as compared with that in the nonylphenol and MPP(+)-treated control. We compared the ability of non-SH-containing enalaprilat with a SH-containing captopril to scavenge OH and DA efflux. Both inhibitors were able to scavenge *OH and DA efflux induced by para-nonylphenol and MPP(+). The results suggest that angiotensin-converting enzyme inhibitors may protect against nonylphenol and MPP(+)-induced *OH formation via suppressing DA efflux in the rat striatum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18611425     DOI: 10.1016/j.tox.2008.06.005

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  4 in total

1.  Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP+ Toxicity In Vivo.

Authors:  Natalia Moreno-Galarza; Liliana Mendieta; Victoria Palafox-Sánchez; Mireia Herrando-Grabulosa; Carles Gil; Daniel I Limón; José Aguilera
Journal:  Neurotox Res       Date:  2018-02-19       Impact factor: 3.911

2.  The insertion/deletion polymorphism in the angiotensin-converting enzyme gene and nicotine dependence in schizophrenia patients.

Authors:  Sergej Nadalin; Smiljana Ristić; Jelena Rebić; Vesna Šendula Jengić; Miljenko Kapović; Alena Buretić-Tomljanović
Journal:  J Neural Transm (Vienna)       Date:  2016-12-27       Impact factor: 3.575

3.  The lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis.

Authors:  Sergej Nadalin; Alena Buretić-Tomljanović; Polona Lavtar; Nada Starčević Čizmarević; Alenka Hodžić; Juraj Sepčić; Miljenko Kapović; Borut Peterlin; Smiljana Ristić
Journal:  Brain Behav       Date:  2016-11-14       Impact factor: 2.708

Review 4.  Risk of Parkinson's Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational Studies.

Authors:  Amarnath Mullapudi; Kapil Gudala; Chandra Sekhar Boya; Dipika Bansal
Journal:  J Neurodegener Dis       Date:  2016-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.